Literature DB >> 30191024

Liver cancer screening in high-risk populations.

Morris Sherman1.   

Abstract

Patients with liver disease have a risk of developing hepatocellular carcinoma (HCC), but the risk varies between different diseases and is also different according to several other variables, such as age, type of underlying liver disease and severity of disease. Several risk scores have been developed to more adequately quantitate HCC risk in individual patients. Each risk score is applicable to a specific population (chronic hepatitis B or C, patients on the transplant list, cirrhosis in general, and so on). Most publications on risk scores do not provide clear guidance as to what level of measured risk is sufficient to trigger surveillance.

Entities:  

Year:  2015        PMID: 30191024      PMCID: PMC6095323          DOI: 10.2217/hep.15.35

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  32 in total

1.  Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.

Authors:  Jennifer A Flemming; Ju Dong Yang; Eric Vittinghoff; W Ray Kim; Norah A Terrault
Journal:  Cancer       Date:  2014-07-16       Impact factor: 6.860

2.  Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).

Authors:  Kyu Sik Jung; Seung Up Kim; Sang Hoon Ahn; Young Nyun Park; Do Young Kim; Jun Yong Park; Chae Yoon Chon; Eun Hee Choi; Kwang-Hyub Han
Journal:  Hepatology       Date:  2011-02-11       Impact factor: 17.425

3.  Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

Authors:  Vincent Wai-Sun Wong; Stephen Lam Chan; Frankie Mo; Tung-Ching Chan; Herbert Ho-Fung Loong; Grace Lai-Hung Wong; Yanni Yan-Ni Lui; Anthony Tak-Cheung Chan; Joseph Jao-Yiu Sung; Winnie Yeo; Henry Lik-Yuen Chan; Tony Shu-Kam Mok
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

4.  A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.

Authors:  Hashem B El-Serag; Fasiha Kanwal; Jessica A Davila; Jennifer Kramer; Peter Richardson
Journal:  Gastroenterology       Date:  2014-01-23       Impact factor: 22.682

5.  Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases.

Authors:  Chi-Pang Wen; Jie Lin; Yi Chen Yang; Min Kuang Tsai; Chwen Keng Tsao; Carol Etzel; Maosheng Huang; Chung Yi Hsu; Yuanqing Ye; Lopa Mishra; Ernest Hawk; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2012-10-17       Impact factor: 13.506

6.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

7.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

8.  Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area.

Authors:  Ze Zheng; Chao Zhang; Jianhua Yan; Yanping Ruan; Xiaoyi Zhao; Xingting San; Yilei Mao; Qinghua Sun; Kezhong Zhang; Zhongjie Fan
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

9.  Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians.

Authors:  Pauline Arends; Milan J Sonneveld; Roeland Zoutendijk; Ivana Carey; Ashley Brown; Massimo Fasano; David Mutimer; Katja Deterding; Jurriën G P Reijnders; Ye Oo; Jörg Petersen; Florian van Bömmel; Robert J de Knegt; Teresa Santantonio; Thomas Berg; Tania M Welzel; Heiner Wedemeyer; Maria Buti; Pierre Pradat; Fabien Zoulim; Bettina Hansen; Harry L A Janssen
Journal:  Gut       Date:  2014-07-10       Impact factor: 23.059

10.  Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy.

Authors:  K-C Chang; Y-Y Wu; C-H Hung; S-N Lu; C-M Lee; K-W Chiu; M-C Tsai; P-L Tseng; C-M Huang; C-L Cho; H-H Chen; T-H Hu
Journal:  Br J Cancer       Date:  2013-10-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.